Basic Information
Basic information for TMEM161B-AS1-227-13aa-3
Peptide Name TMEM161B-AS1-227-13aa-3
Genome Position chr5:88292690-88292728[+]
Species Human
Peptide Sequence MFFLLKNAIEIRV
Peptide Length 13
Unique No (TMEM161B-AS1-211-13aa,TMEM161B-AS1-215-13aa-3,TMEM161B-AS1-216-13aa-3,TMEM161B-AS1-225-13aa-4,TMEM161B-AS1-230-13aa-3,TMEM161B-AS1-237-13aa,TMEM161B-AS1-238-13aa-2,TMEM161B-AS1-241-13aa-4,TMEM161B-AS1-245-13aa-2,TMEM161B-AS1-248-13aa-2,TMEM161B-AS1-254-13aa-2,TMEM161B-AS1-257-13aa-5,TMEM161B-AS1-258-13aa-3)
Grand Average of Hydropathicity 1.1308
Relative Molecular Mass 1810.15
Experimental Evidences 1:ribo
lncRNA ID/Name ENSG00000247828;TMEM161B-AS1
Transcript ID/Name ENST00000658611;TMEM161B-AS1-227
Transcript Length 2228
Coding Ability 0.3299
DNA Sequence Corresponding to Peptide ATGTTTTTCTTATTGAAGAATGCCATAGAAATAAGGGTG
Experimental Evidences
   Occupancy of Ribosomes
Tissue :    
Expression type:    Count RPKM
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :